DNLI
Price
$14.70
Change
+$0.48 (+3.38%)
Updated
Jun 6 closing price
Capitalization
2.07B
53 days until earnings call
ELVN
Price
$20.74
Change
-$0.63 (-2.95%)
Updated
Jun 6 closing price
Capitalization
1.05B
60 days until earnings call
Interact to see
Advertisement

DNLI vs ELVN

Header iconDNLI vs ELVN Comparison
Open Charts DNLI vs ELVNBanner chart's image
Denali Therapeutics
Price$14.70
Change+$0.48 (+3.38%)
Volume$1.79M
Capitalization2.07B
Enliven Therapeutics
Price$20.74
Change-$0.63 (-2.95%)
Volume$663.45K
Capitalization1.05B
DNLI vs ELVN Comparison Chart
Loading...
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ELVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DNLI vs. ELVN commentary
Jun 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNLI is a Hold and ELVN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 08, 2025
Stock price -- (DNLI: $13.04 vs. ELVN: $16.07)
Brand notoriety: DNLI and ELVN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DNLI: 82% vs. ELVN: 82%
Market capitalization -- DNLI: $2.07B vs. ELVN: $1.05B
DNLI [@Biotechnology] is valued at $2.07B. ELVN’s [@Biotechnology] market capitalization is $1.05B. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNLI’s FA Score shows that 0 FA rating(s) are green whileELVN’s FA Score has 0 green FA rating(s).

  • DNLI’s FA Score: 0 green, 5 red.
  • ELVN’s FA Score: 0 green, 5 red.
According to our system of comparison, ELVN is a better buy in the long-term than DNLI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNLI’s TA Score shows that 3 TA indicator(s) are bullish while ELVN’s TA Score has 4 bullish TA indicator(s).

  • DNLI’s TA Score: 3 bullish, 6 bearish.
  • ELVN’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ELVN is a better buy in the short-term than DNLI.

Price Growth

DNLI (@Biotechnology) experienced а -4.75% price change this week, while ELVN (@Biotechnology) price change was -5.08% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

DNLI is expected to report earnings on Jul 31, 2025.

ELVN is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNLI($2.07B) has a higher market cap than ELVN($1.05B). ELVN YTD gains are higher at: -28.578 vs. DNLI (-36.016). ELVN has higher annual earnings (EBITDA): -104.24M vs. DNLI (-492.89M). DNLI has more cash in the bank: 832M vs. ELVN (313M). ELVN has less debt than DNLI: ELVN (0) vs DNLI (48.7M). DNLI (0) and ELVN (0) have equivalent revenues.
DNLIELVNDNLI / ELVN
Capitalization2.07B1.05B197%
EBITDA-492.89M-104.24M473%
Gain YTD-36.016-28.578126%
P/E RatioN/AN/A-
Revenue00-
Total Cash832M313M266%
Total Debt48.7M0-
FUNDAMENTALS RATINGS
DNLI: Fundamental Ratings
DNLI
OUTLOOK RATING
1..100
65
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
90
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DNLIELVN
RSI
ODDS (%)
Bearish Trend 12 days ago
89%
N/A
Stochastic
ODDS (%)
Bullish Trend 12 days ago
75%
Bullish Trend 12 days ago
79%
Momentum
ODDS (%)
Bearish Trend 12 days ago
81%
Bearish Trend 12 days ago
90%
MACD
ODDS (%)
Bearish Trend 12 days ago
76%
Bearish Trend 12 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 12 days ago
83%
Bearish Trend 12 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 12 days ago
85%
Bearish Trend 12 days ago
87%
Advances
ODDS (%)
Bullish Trend 20 days ago
78%
Bullish Trend 27 days ago
81%
Declines
ODDS (%)
Bearish Trend 12 days ago
80%
Bearish Trend 13 days ago
90%
BollingerBands
ODDS (%)
N/A
Bullish Trend 12 days ago
75%
Aroon
ODDS (%)
Bullish Trend 12 days ago
69%
Bullish Trend 12 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ELVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

DNLI and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNLI has been loosely correlated with BEAM. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if DNLI jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNLI
1D Price
Change %
DNLI100%
-1.29%
BEAM - DNLI
61%
Loosely correlated
-0.88%
RCKT - DNLI
59%
Loosely correlated
+6.44%
NTLA - DNLI
59%
Loosely correlated
+3.59%
ARWR - DNLI
58%
Loosely correlated
+1.24%
RGNX - DNLI
58%
Loosely correlated
-5.84%
More

ELVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ELVN has been loosely correlated with APGE. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if ELVN jumps, then APGE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELVN
1D Price
Change %
ELVN100%
+0.50%
APGE - ELVN
52%
Loosely correlated
-1.30%
ERAS - ELVN
49%
Loosely correlated
+1.85%
BHVN - ELVN
47%
Loosely correlated
-1.83%
DNLI - ELVN
46%
Loosely correlated
-1.29%
COGT - ELVN
46%
Loosely correlated
N/A
More